Patent US6143948A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6143948A Expired / Lapsed US ⏱️ 0.0 years remaining

Device for incorporation and release of biologically active agents

Assignee: Chienna BV
•
Filing: 1997-07-03
•
Granted: 2000-11-07
•
Expires: 2017-07-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides an implantable device coated with a layer of calcium phosphate and optionally one or more biologically active substances such as growth factors, lipids, (lipo)polysaccharides, hormones, proteins, antibiotics or cytostatics. The device can be obtained by a nanotechnology process comprising subjecting a substrate to a surface treatment until a surface roughness with an average peak distance (Ra value) between 10 and 1,000 nm and subjecting the roughened surface to precipitation of calcium phosphate from a solution containing calcium and phosphate ions with optional coprecipitation of the biologically active substance.

Inventors

  • 👤 Eugenia Ribeiro de Sousa Fidalgo Leitao
  • 👤 Joost Dick De Bruijn
  • 👤 Hai-Bo Wen
  • 👤 Klaas de Groot

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 22:46
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/54; A61F; A61F2/00; A61F2/02; A61F2/30; A61F2/30767; A61L27/28; A61L27/30; A61L27/32; A61F2002/30001; A61F2002/30667; A61F2002/30677; A61F2002/30906; A61F2310/00; A61F2310/00005; A61F2310/00011; A61F2310/00023; A61F2310/00179; A61F2310/00389; A61F2310/00592; A61F2310/00796; A61F2310/0097; A61F2310/00976; A61L2300/00; A61L2300/20; A61L2300/22; A61L2300/23; A61L2300/232; A61L2300/252; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/412; A61L2300/414; A61L2300/416; A61L2300/43; A61L2300/60; A61L2300/606

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 75 words
An implantable device comprising a material having a precipitate enhancing roughened surface, before coating with an average peak distance between 10 nm and 1,000 nm and having an average depth, wherein the roughened surface is coated in vitro with a layer of a precipitate comprising calcium ions, phosphate ions, and an organic biologically active agent wherein at least a portion of the layer has a thickness greater than the average depth of the roughened surface.
Claim 2
Dependent Claim 75 words
An implantable device comprising a material having a precipitate enhancing roughened surface, before coating with an average peak distance between 10 nm and 1,000 nm and having an average depth, wherein the roughened surface is coated in vitro with a layer of a precipitate comprising calcium ions, phosphate ions, and an organic biologically active agent wherein at least a portion of the layer has a thickness greater than the average depth of the roughened surface.
Claim 3
Dependent Claim 32 words
The implantable device according to claim 1, wherein the organic biologically active agent is selected from the group consisting of growth factors, lipids, (lipo)polysaccharides, cytostatic agents, hormones, antibiotics, proteins, and mixtures thereof.
Claim 4
Dependent Claim 25 words
The implantable device according to claim 1, wherein the roughened surface, before coating, has an average depth between about 20 nm and about 2,000 nm.
Claim 5
Dependent Claim 21 words
The implantable device according to claim 1, wherein the layer has a thickness of about 50 nm to about 200 μm.
Claim 6
Dependent Claim 34 words
The implantable device according to claim 1, wherein the material is selected from the group consisting of a metal, a metal alloy, a ceramic material, a natural or synthetic polymer and a composite thereof.
Claim 7
Dependent Claim 40 words
A method of implanting a member selected from the group consisting of a bone substitute, a joint prosthesis, a dental implant, a maxillofacial implant, a vertebral surgery aid, and a transcutaneous device, comprising implanting a device according to claim 1.
Claim 8
Dependent Claim 15 words
The implantable device according to claim 1 wherein the layer is an amorphous crystalline layer.
Claim 9
Dependent Claim 40 words
The implantable device according to claim 1 wherein the layer comprises calcium ions and phosphate ions and one or more ions selected from the group consisting of hydroxide, chloride, sulphate, and nitrate anions and hydrogen, sodium, potassium and magnesium cations.
Claim 10
Dependent Claim 14 words
The implantable device according to claim 1 wherein the layer does not comprise hydroxyapatite.
Claim 11
Dependent Claim 22 words
The implantable device according to claim 5 wherein the metal is titanium or tantalum and the metal alloy is a titanium alloy.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-11-07 2004-05-08 2004-11-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-11-07 2008-05-08 2008-11-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-11-07 2012-05-08 2012-11-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag